Antigenic profile of African horse sickness virus serotype 4 VP5 and identification of a neutralizing epitope shared with bluetongue virus and epizootic hemorrhagic disease virus.

The study examines the VP5 protein of the African horse sickness virus (AHSV), highlighting its ability to induce virus-specific neutralizing antibodies and identifying shared neutralizing epitopes among AHSV, bluetongue virus, and epizootic hemorrhagic disease virus.

Investigation into AHSV’s VP5 Protein

• The investigation begins with the study of African horse sickness virus (AHSV), a highly fatal disease affecting horses. The virus’s capsid – the outer shell of a virus particle – is composed of a double protein layer, primarily from proteins VP2 and VP5.
• This study mainly centres around VP5, known to be a part of the virus’s outer casing but with previously unknown biological function. The researchers find that the VP5 protein, when expressed in insect cells alone or together with VP2, can induce AHSV-specific neutralizing antibodies. Neutralizing antibodies can neutralize the infectivity of pathogens like viruses.

Dissection of VP5 Antigenic Structure

• To further understand the antigenic structure of VP5, it is cloned using E. coli and the pET3 system. Antigens stimulate your immune system to produce antibodies, hence studying their structure is vital to the development of treatments and vaccines.
• Using different antibodies and polyclonal antisera, the immunoreactivity with 17 overlapping fragments of VP5 is analyzed. They discover that VP5’s most immunodominant region is located in residues 151-200 and residues 83-120 of its N-terminal 330 residues.
• Through PEPSCAN analysis, eight antigenic or immunogenic sites are determined in the N-terminal half of the VP5 molecule.

Identification of Neutralizing Epitopes

• Upon inspection, the researchers find neutralizing epitopes located at positions 85-92 and 179-185 for the monoclonal antibodies (MAb) 10AE12 and 10AC6 respectively.
• An exciting discovery is that the 10AE12 epitope is highly conserved among distinct orbiviruses, as MAb 10AE12 can recognize VP5 variants from bluetongue viruses and epizootic hemorrhagic disease viruses.

Implications of the Findings

• The findings present useful possibilities for both diagnostic purposes and vaccine development.
• This is because the discovery of neutralizing epitopes leads to more effective treatment strategies, and recognizing highly conserved epitopes may allow for more universal vaccines covering different diseases caused by orbiviruses.